SCHEMBL17760

SCHEMBL17760

CCCN(C[C@H]1CNCCN1)S(C)(=O)=O

nearest known ligand 0.36

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.36
CA12 O43570 1/20 0.36
CA2 P00918 1/20 0.36
CA14 Q9ULX7 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17884 0.80 PER2 (0.32)
Hydrochloric Acid SCHEMBL17279 0.79 PER2 (0.31)
SCHEMBL26628972 0.75 CXCR4 (0.32)
SCHEMBL17759 0.74
Hydrochloric Acid SCHEMBL17306 0.73
SCHEMBL12473958 0.71 CA1 (0.33) CA1CA12CA2CA14
SCHEMBL10041484 0.69 CA1 (0.43) CA1CA12CA2CA14
SCHEMBL16261610 0.69 CA1 (0.46) CA1CA12CA2CA14
SCHEMBL16908265 0.69 PARP1 (0.33)
SCHEMBL20742418 0.69 PARP1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2609081-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES Amgen Inc. (US) 2013-07-03 EP disclosed
WO-2012027261-A1 SULFONYLPIPERAZINE DERIVATIVES THAT INTERACT WITH GLUCOKINASE REGULATORY PROTEIN FOR THE TREATMENT OF DIABETES AMGEN INC. (US) 2012-03-01 WO disclosed